140592-How do we combat bogus medicines in the age of the COVID-19 Pandemic.pdf (84.78 kB)
How do we combat bogus medicines in the age of the COVID-19 pandemic?
journal contribution
posted on 2023-05-20, 17:17 authored by Tesfaye, W, Abrha, S, Sinnollareddy, M, Arnold, B, Brown, A, Matthew, C, Oguoma, VM, Gregory PetersonGregory Peterson, Thomas, JThe COVID-19 pandemic has brought concurrent challenges. The increased incidence of fake and falsified product distribution is one of these problems with tremendous impact, especially in low- and middle-income countries. Up to a tenth of medicines including antibiotics and antimalarial drugs in the African market are considered falsified. Pandemics make this worse by creating an ecosystem of confusion, distraction, and vulnerability stemming from the pandemic as health systems become more stressed and the workload of individuals increased. These environments create opportunities for substandard and falsified medicines to be more easily introduced into the marketplace by unscrupulous operators. In this work, we discussed some of the challenges with fake or falsified product distribution in the context of COVID-19 and proposed strategies to best manage this problem.
History
Publication title
American Journal of Tropical Medicine and HygieneVolume
103Issue
4Pagination
1360-1363ISSN
0002-9637Department/School
School of Pharmacy and PharmacologyPublisher
Amer Soc Trop Med & HygienePlace of publication
8000 Westpark Dr, Ste 130, Mclean, USA, Va, 22101Rights statement
Copyright 2020 by The American Society of Tropical Medicine and Hygiene. Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/Repository Status
- Open